ADVENTRX Pharmaceuticals Inc. (ANX) and Pierre Fabre Announce Manufacturing Agreement for ANX-188 Drug Substance
6/12/2012 10:55:07 AM
More...
|
Pierre Fabre Selects Dassault Systèmes SolidWorks Corp.' Version 6 Platform to Deploy Next-Generation PLM for Life Sciences
11/22/2011 10:01:54 AM
More...
|
Sales of Dermo-Cosmetics on the Internet: Ruling by the EU Court of Justice Allows Pierre Fabre to Defend Their Right to an Individual Exemption
10/13/2011 12:11:56 PM
More...
|
MediGene AG (MDGEF.PK) and Pierre Fabre Sign Agreement for the Commercialization of Veregen(R) in Mexico, Central America, Venezuela and Colombia
2/22/2011 11:05:33 AM
More...
|
Forest Laboratories, Inc. (FRX) and Pierre Fabre Announce Topline Phase III Results from a Study of Levomilnacipran for the Treatment of Major Depressive Disorder; Drug Fails to Meet Statistical Significance
1/20/2011 6:34:06 AM
More...
|
Pierre Fabre's Bladder Cancer Drug, Javlor too Costly for National Health Service, National Institute for Clinical Excellence (NICE) Says
11/23/2010 7:40:42 AM
More...
|
Pierre Fabre to Strengthen Partnership with Cegedim Dendrite
3/29/2010 10:03:34 AM
More...
|
Abbott Laboratories (ABT) (JOBS) Enters Into Cancer Pact with France's Pierre Fabre; Abbott to Pay $25 Million
2/2/2010 7:03:42 AM
More...
|
Forest Laboratories, Inc. (FRX) Gains Rights to Pierre Fabre Anti-depressant for $75 Million
12/22/2008 7:09:50 AM
More...
|
Pierre Fabre Donates the Majority Equity Interest in his Company to his Foundation
9/5/2008 9:05:37 AM
More...
|
|